Mark C. Griffiths Named Carbogen Amcis CEO

New Carbogen Amcis CEO Mark Griffiths
New Carbogen Amcis CEO Mark Griffiths

Switzerland-based Carbogen Amcis, a pharmaceutical process development and API manufacturing company, announced that Mark C. Griffiths has been named chief executive officer, effective immediately. In his new role, Griffiths will have responsibility for the company's Swiss business and will report to Jay Vyas, managing director of Dishman Pharmaceuticals and Chemicals, Carbogen Amcis' parent company.

Griffiths has been associated with Carbogen Amcis as director of operations and chief executive officer for almost 10 years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group's large-scale manufacturing facilities for commercial supply of highly potent APIs (HPAPIs) in Shanghai, China, and Ahmedabad, India.

 

Company

Dishman Europe Ltd.

120 New Cavendish St.
W1W 6XX London

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.